参考文献/References:
[1] 章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322-324.
[2] 朱绍华,何创业,赵 芯.圆柱瘤蛋白、白细胞介素-6、白细胞介素-8在结直肠癌及癌前病变中的表达差异及其与患者临床病理特征的关系[J].陕西医学杂志,2022,51(12):1602-1606.
[3] Yuan CH,Hsu WC,Huang AM,et al.MicroRNA-145-5p modulates Krüppel-like factor 5 and inhibits cell proliferation,migration,and invasion in nasopharyngeal carcinoma[J].BMC Mol Cell Biol,2022,23(1):28.
[4] Luo AY,Liu HL,Huang C.KLF5-induced miR-487a augments the progression of osteosarcoma cells by targeting NKX3-1 in vitro[J].Oncol Lett,2022,24(2):258.
[5] Takagi Y,Sakai N,Yoshitomi H,et al.High expression of Krüppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer[J].Cancer Sci,2020,111(6):2078-2092.
[6] Shen XH,Zhang YC,Xu ZQ,et al.KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response[J].Cell Death Dis,2022,13(4):303.
[7] Zhang YH,Sun LB,Lei CD,et al.A Sweet warning:Mucin-type O-glycans in cancer[J].Cells,2022,11(22):3666.
[8] Chen LP,Li Y,Song ZH,et al.O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling[J].Proc Natl Acad Sci USA,2022,119(34):e2202821119.
[9] Zhu Q,Zhou H,Wu LM,et al.O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1[J].Nat Chem Biol,2022,18(10):1087-1095.
[10] 朱文侠,杨 玲,成 钧,等.miR-142-3p在结直肠癌组织与细胞中的表达及对细胞增殖影响研究[J].陕西医学杂志,2018,47(3):282-286.
[11] Dai XD,Chen Y,Chen N,et al.KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer[J].Immunopharmacol Immunotoxicol,2022,20:1-13.
[12] Hegazy SE,Bailey NG.Progression of CCND1-in situ mantle cell neoplasia to CCND1-mantle cell lymphoma[J].Blood,2022,140(10):1182.
[13] 李正华,纪 涛,任建政,等.穗花杉双黄酮对骨肉瘤细胞增殖及周期相关蛋白的影响[J].陕西医学杂志,2022,51(5)534-538.
[14] Xie H,Lv SG,Wang ZZ,et al.E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA-107 to augment progression of glioma[J].Brain Behav,2021,11(12):e2399.
[15] Lin JY,Xiang YT,Huang JA,et al.NAT10 maintains OGA mRNA stability through ac4c modification in regulating oocyte maturation[J].Front Endocrinol(Lausanne),2022,13:907286.
[16] Yin XM,Li YY,Fan X,et al.SIRT1 deficiency increases O-GlcNAcylation of tau,mediating synaptic tauopathy[J].Mol Psychiatry,2022,27(10):4323-4334.
[17] Wang YQ,Fang XW,Wang S,et al.The role of O-GlcNAcylation in innate immunity and inflammation[J].J Mol Cell Biol,2023,14(9):65.
[18] Wenzel DW,Stichelen SO.The O-GlcNAc cycling in neurodevelopment and associated diseases[J].Biochem Soc Trans,2022,50(6):1693-1702.
[19] Hu CW,Xie JS,Jiang JY.The emerging roles of protein interactions with O-GlcNAc cycling enzymes in cancer[J].Cancers(Basel),2022,14(20):5135.
[20] Shin EM,Huynh VT,Neja SA,et al.GREB1:An evolutionarily conserved protein with a glycosyltransferase domain links ERα glycosylation and stability to cancer[J].Sci Adv,2021,7(12):2470.
[21] Zhou FN,Ma J,Zhu YF,et al.The role and potential mechanism of O-glycosylation in gastrointestinal tumors[J].Pharmacol Res,2022,184:106420.
相似文献/References:
[1]柯东平,毛俊倩,刘 琪,等.TRIM21调控人结直肠癌细胞增殖分子机制研究*[J].陕西医学杂志,2019,(6):691.
KE Dongping,MAO Junqian,LIU Qi,et al.Study on molecular mechanisms of TRIM21 in regulating proliferation of colorectal cancer[J].,2019,(12):691.
[2]张 慧,陈景志,陈建立△,等.DCC和MKK4基因在结直肠癌组织中的表达及临床意义*[J].陕西医学杂志,2019,(8):968.
ZHANG Hui,CHEN Jingzhi,CHEN Jianli,et al.Expression and clinical significance of DDC and MKK4 genes in colorectal cancer tissue[J].,2019,(12):968.
[3]高怀军,余 伟.腹腔镜结直肠癌根治术治疗结直肠癌临床疗效及对患者胃肠功能的影响[J].陕西医学杂志,2019,(8):990.
GAO Huaijun,YU Wei..Clinical study of laparoscopic radical resection in the treatment of colorectal cancer in and its influence on gastrointestinal function[J].,2019,(12):990.
[4]赵英旋,白玉勤.结直肠癌患者肿瘤出芽情况与临床病理特征、程序性死亡受体1及程序性死亡配体1表达相关性研究[J].陕西医学杂志,2021,50(6):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
ZHAO Yingxuan,BAI Yuqin.Correlation between tumor budding and clinicopathological characteristics,expression of PD-1 and PD-L1 in CRC[J].,2021,50(12):747.[doi:DOI:10.3969/j.issn.1000-7377.2021.06.027]
[5]马 骞,朱 军,蔡梦珊,等.基于exoRBase外泌体数据库结直肠癌竞争性内源RNA网络构建及富集分析[J].陕西医学杂志,2021,50(7):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
MA Qian,ZHU Jun,CAI Mengshan,et al.Construction and enrichment analysis of competing endogenous RNA network for colorectal cancer based on the exoRBase database[J].,2021,50(12):797.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.007]
[6]章玉玲,周 岳.结直肠癌患者血清循环肿瘤细胞、糖类抗原24-2、糖类抗原19-9水平及其与临床病理特征关系[J].陕西医学杂志,2022,51(3):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
ZHANG Yuling,ZHOU Yue.Serum circulating tumor cells,carbohydrate antigen 24-2 and carbohydrate antigen 19-9 levels in patients with colorectal cancer and their relationship with clinicopathological features[J].,2022,51(12):322.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.013]
[7]张利伟,胡海燕.粪便硫酸类肝素蛋白多糖2与分泌型卷曲相关蛋白2基因甲基化检测在结直肠癌筛查中的应用价值[J].陕西医学杂志,2022,51(3):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
ZHANG Liwei,HU Haiyan.Application value of feces detection of syndecan-2 and secreted frizzled related protein 2 gene methylation in colorectal cancer screening[J].,2022,51(12):366.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.024]
[8]曹巍巍,郭修田.结直肠癌原位移植造模技术研究进展[J].陕西医学杂志,2022,51(6):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
CAO Weiwei,GUO Xiutian.Research progress of orthotopic transplantation technology for colorectal cancer[J].,2022,51(12):764.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.029]
[9]张言言,韩 刚,曹 羽,等.同源盒基因10调控胰岛素样生长因子结合蛋白3与肠癌细胞5-氟尿嘧啶抵抗的关系研究[J].陕西医学杂志,2022,51(7):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
ZHANG Yanyan,HAN Gang,CAO Yu,et al.Relationship between regulation of IGFBP3 by HOXD10 and 5-fluorouracil resistance in colorectal cancer cells[J].,2022,51(12):771.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.001]
[10]张晓峰,冯 景,季飞燕,等.结直肠癌术后辅助化疗患者肠内营养不耐受影响因素及小野寺预后营养指数预测价值分析[J].陕西医学杂志,2022,51(9):1114.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.016]